Chemically defined medium for susceptibility testing of antimicrobial agents.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 429868)

Published in Antimicrob Agents Chemother on December 01, 1976

Authors

P F Dougherty, D L Yotter, T R Matthews

Articles by these authors

Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine. Antimicrob Agents Chemother (1983) 2.58

Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J Infect Dis (1991) 2.43

9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine: a new potent and selective antiherpes agent. J Med Chem (1983) 1.90

Intracellular metabolism and enzymatic phosphorylation of 9-(1,3-dihydroxy-2-propoxymethyl)guanine and acyclovir in herpes simplex virus-infected and uninfected cells. Biochem Pharmacol (1985) 1.83

Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses. Antimicrob Agents Chemother (1985) 1.37

Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice. Infect Immun (1981) 1.33

Microdilution transfer plate technique for determining in vitro synergy of antimicrobial agents. Antimicrob Agents Chemother (1977) 1.20

Protective effect of a muramyl dipeptide analog encapsulated in or mixed with liposomes against Candida albicans infection. Infect Immun (1983) 1.17

Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice. Infect Immun (1982) 1.16

1-[4-(4-Chlorophenyl)-2-(2,6-dichlorophenylthio)-n-butyl]-1H-imidazole nitrate, a new potent antifungal agent. J Med Chem (1978) 1.10

New class of antifungal agents: jasplakinolide, a cyclodepsipeptide from the marine sponge, Jaspis species. Antimicrob Agents Chemother (1988) 1.10

Metabolism of ribavirin in respiratory syncytial virus-infected and uninfected cells. Antimicrob Agents Chemother (1986) 1.10

Enhanced efficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine in combination with beta-interferon against herpes simplex virus type 2 in mice. Antimicrob Agents Chemother (1984) 1.07

Evaluation of the in vitro and in vivo antifungal activity of pyrrolnitrin. Antimicrob Agents Chemother (Bethesda) (1967) 1.06

Synthesis and antimicrobial activity of some novel heterocycles. Azolo-as-triazines. J Med Chem (1976) 1.01

Efficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine against primary and recrudescent genital herpes simplex virus type 2 infections in guinea pigs. Antimicrob Agents Chemother (1983) 0.99

Synthesis and antifungal properties of certain 7-alkylaminopyrazolo[1,5-a]pyrimidines. J Med Chem (1977) 0.96

Reliable technique for plating pathogenic fungi from organ homogenates. Appl Microbiol (1968) 0.93

Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo. Antiviral Res (1989) 0.92

In vitro and in vivo activities of phosphate derivatives of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine against cytomegaloviruses. Antiviral Res (1986) 0.91

Activities of arabinosyladenine monophosphate and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against ground squirrel hepatitis virus in vivo as determined by reduction in serum virion-associated DNA polymerase. Antimicrob Agents Chemother (1985) 0.89

Efficacy of interleukin-1 beta against systemic Candida albicans infections in normal and immunosuppressed mice. Infect Immun (1989) 0.88

Synthesis and antimicrobial activity of certain imidazo[1,2-a]pyrimidines. J Med Chem (1975) 0.88

Comparative anti-herpesvirus activities of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, acyclovir, and two 2'-fluoropyrimidine nucleosides. Antiviral Res (1985) 0.87

Synthesis and anti-herpes-virus activity of acyclic 2'-deoxyguanosine analogues related to 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine. J Med Chem (1986) 0.87

Effect of ketorolac on Pseudomonas aeruginosa ocular infection in rabbits. J Ocul Pharmacol (1988) 0.83

7-Ribosyl-3-deazaguanine--mechanism of antibacterial action. Biochem Pharmacol (1980) 0.82

Effect of ketorolac on Candida albicans ocular infection in rabbits. Arch Ophthalmol (1987) 0.82

Synthesis and antiherpes virus activity of phosphate and phosphonate derivatives of 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine. J Med Chem (1986) 0.82

Imidazo(1,2-c)pyrimidine nucleosides. Synthesis and biological evaluation of certain 1-(beta-D-arabinofuranosyl)imidazo(1,2-c)pyrimidines. J Med Chem (1976) 0.82

Systemic antifungal activity of pyrrolnitrin. Appl Microbiol (1969) 0.82

Synthesis of 5-amino-1-(5-deoxy-beta-D-ribofuranosyl)imidazole-4-carboxamide and related 5'-deoxyimidazole ribonucleosides. J Med Chem (1975) 0.81

Differentiation in Coprinus lagopus. I. Control of fruiting and cytology in initial events. Arch Mikrobiol (1972) 0.80

Enhanced efficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine in combination with alpha-interferon against herpes simplex virus type 2 in mice. Antimicrob Agents Chemother (1984) 0.79

Synthesis and antiviral and antimicrobial activity of certain 1-beta-D-ribofuranosyl-4,5-disubstituted imidazoles. J Med Chem (1976) 0.78

Kinetics and inhibition of reverse transcriptase from human and simian immunodeficiency viruses. Antimicrob Agents Chemother (1988) 0.77

Enhanced efficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine in combination with gamma interferon against herpes simplex virus type 2 in mice. Antiviral Res (1985) 0.77

Differentiation in Coprinus lagopus. II. Histology and ultrastructural aspects of developing primordia. Arch Mikrobiol (1973) 0.77

Acyclic analogues of 2'-deoxynucleosides related to 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine as potential antiviral agents. J Med Chem (1985) 0.77

Efficacy of ganciclovir in combination with other antimicrobial agents against cytomegalovirus in vitro and in vivo. Antiviral Res (1993) 0.76

Evaluation of systemic antifungal agents in X-irradiated mice. Appl Microbiol (1970) 0.75

Lack of efficacy of AMP against recrudescent genital herpes infections in guinea pigs. Antimicrob Agents Chemother (1983) 0.75

Effect of ketorolac on herpes simplex virus type one ocular infection in rabbits. J Ocul Pharmacol (1988) 0.75

Effect of salmon calcitonin on plasma calcium and phosphorus in pregnant and non-pregnant guinea pigs. Miner Electrolyte Metab (1982) 0.75

Fermentation, isolation, and biological properties of mycophenolic acid. Antimicrob Agents Chemother (Bethesda) (1968) 0.75

Synthesis and antiherpes simplex virus activity of 9-[(1,3-dihydroxy-2-propylthio)methyl]guanine. J Med Chem (1985) 0.75

Susceptibility testing of herpes viruses. Clin Lab Med (1989) 0.75

Effect of ketorolac on phagocytosis of Candida albicans by peritoneal macrophages. Immunopharmacology (1989) 0.75

Antitrichomonal activity of mesoionic thiazolo[3,2-a]pyridines. J Med Chem (1985) 0.75

Synthesis and antimicrobial evaluation of substituted 5,6-dihydro-5-nitrouracils. J Med Chem (1976) 0.75

The efficacy of an N-substituted imidazole, RS-49676, against a Trypanosoma cruzi infection in mice. Am J Trop Med Hyg (1987) 0.75

Detection of precipitins against Brucella ovis. Cornell Vet (1967) 0.75

Lack of antiviral activity of ketoconazole alone or in combination with the acyclic nucleoside ganciclovir against a herpes virus type 2 infection in mice. Acta Virol (1989) 0.75